DEBORAH MILLER: Open Payments
NPI 1972843464 · WESTON, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$227 in 10 payments from 7 companies in 2025. Trend: 2023 $420 · 2024 $704 · 2025 $227
Food & beverage: $227
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 3 | $62 |
| Axsome Therapeutics, Inc. | 2 | $49 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
| Supernus Pharmaceuticals, Inc. | 1 | $25 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
| Alkermes, Inc. | 1 | $17 |
Products named: FANAPT, Auvelity, UZEDY, REXULTI, Qelbree, SPRAVATO, ARISTADA.
Industry payments across WI — which companies pay providers there.
